Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.7 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |